Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

OBJECTIVE: We compared the metabolic and cardiovascular parameters of a reference group of women with those of women who used 2 contraceptive regimes that are used worldwide: the levonorgestrel-releasing intrauterine device and oral contraceptives. STUDY DESIGN: We investigated a cohort of 2814 wom...

Descripció completa

Dades bibliogràfiques
Autors principals:	Morin-Papunen, L, Martikainen, H, McCarthy, M, Franks, S, Sovio, U, Hartikainen, A, Ruokonen, A, Leinonen, M, Laitinen, J, Järvelin, MR, Pouta, A
Format:	Conference item
Publicat:	2008

Ítems similars

Should long-term hormonal contraception be reconsidered? Metabolic and inflammatory outcomes in women using oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
per: Morin-Papunen, L, et al.
Publicat: (2006)

Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
per: Koivunen, R, et al.
Publicat: (2008)

Contraception: efficacy and safety of levonorgestrel-releasing intrauterine system
per: T Yu Pestrikova, et al.
Publicat: (2015-02-01)

Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
per: Taponen, S, et al.
Publicat: (2004)

Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms.
per: Laitinen, J, et al.
Publicat: (2003)

Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism.
per: Torvinen, A, et al.
Publicat: (2011)

No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth.
per: Bennett, A, et al.
Publicat: (2008)

Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
per: Taponen, S, et al.
Publicat: (2004)

Manifestations of metabolic syndrome after hypertensive pregnancy.
per: Pouta, A, et al.
Publicat: (2004)

Non-contraceptive applications of the levonorgestrel intrauterine system
per: Maria Isabel Rodriguez, et al.
Publicat: (2010-04-01)

PPARG P12A,Kir6.2/KCNJ11 E23K and early growth in the Northern Finland Birth Cohort of 1966
per: Bennett, A, et al.
Publicat: (2005)

No association between insulin gene variation and adult metabolic phenotypes in a large Finnish birth cohort.
per: Bennett, A, et al.
Publicat: (2005)

Detailed analysis of variation at and around mitochondrial position 16189 in a large Finnish cohort reveals no significant associations with early growth or metabolic phenotypes at age 31 years.
per: Das, S, et al.
Publicat: (2007)

Variation at the insulin gene VNTR (variable number tandem repeat) polymorphism and early growth: studies in a large Finnish birth cohort.
per: Bennett, A, et al.
Publicat: (2004)

Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling
per: Costescu DJ
Publicat: (2016-10-01)

Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS.
per: Barber, T, et al.
Publicat: (2007)

Serum sex hormone-binding globulin and testosterone in relation to cardiovascular disease risk factors in young men: a population-based study.
per: Canoy, D, et al.
Publicat: (2014)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
per: Marcia Vieira da Motta, et al.
Publicat: (2013-01-01)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
per: Marcia Vieira da Motta, et al.
Publicat: (2013-06-01)

Contraception with levonorgestrel-releasing intrauterine system versus copper intrauterine device: a meta-analysis of randomized controlled trialsResearch in context
per: Pan Liu, et al.
Publicat: (2024-12-01)

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
per: Elaine Cristina Fontes de Oliveira, et al.
Publicat: (2023-12-01)

Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort.
per: Vääräsmäki, M, et al.
Publicat: (2009)

Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
per: Barber, T, et al.
Publicat: (2007)

Maternal gestational diabetes and the manifestations of metabolic syndrome in adolescent offspring
per: Pouta, A, et al.
Publicat: (2006)

Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS
per: Limei Ji, et al.
Publicat: (2023-12-01)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
per: Hira Imad Cheema, et al.
Publicat: (2017-11-01)

Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 Birth Cohort study.
per: Tzoulaki, I, et al.
Publicat: (2008)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
per: Sangwon Choi, et al.
Publicat: (2021-05-01)

Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma
per: Ching-Jung Lin, et al.
Publicat: (2018-02-01)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
per: Chandra Kailasam, et al.
Publicat: (2008-10-01)

The lost intrauterine levonorgestrel-releasing system in women with adenomyosis: A case report
per: Eka Rusdianto Gunardi, et al.
Publicat: (2022-11-01)

Marked increase of breast density due to a levonorgestrel-releasing intrauterine device
per: J Gossner
Publicat: (2013-11-01)

Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis
per: Dong Soo Park, et al.
Publicat: (2015-08-01)

#378 : Intrauterine Suture of Levonorgestrel Intrauterine Device Under Hysteroscopy
per: Xiaoyu Shi, et al.
Publicat: (2023-12-01)

Weight at birth and infancy in relation to adult leukocyte count: a population-based study of 5619 men and women followed from the fetal period to adulthood.
per: Canoy, D, et al.
Publicat: (2009)

Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
per: Sharad Iyengar, et al.
Publicat: (2022-01-01)

Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo.
per: Marielle Cavrois, et al.
Publicat: (2019-01-01)

Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.
per: Gaasenbeek, M, et al.
Publicat: (2004)

Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits.
per: Powell, B, et al.
Publicat: (2005)

Study of Efficacy and Acceptability of Levonorgestrel-Releasing Intrauterine Device in Heavy Menstrual Bleeding Patients
per: Robina Kousar, et al.
Publicat: (2024-08-01)